Sangani Hospitals Limited — Results, 20-12-2024: Reply to Clarification- Financial results

**Quarterly Financial Summary for Sangani Hospitals Limited**

Consolidated revenue from operations stands at ₹10.01 crore, marking a robust growth from ₹7.67 crore a year ago, translating to a growth rate of approximately 30.7%. This surge can be attributed to increased service demand post-COVID, expansions undertaken, and enhanced patient capacity in their facilities.

Net profit for the half-year is reported at ₹17.08 crore, compared to ₹16.58 crore last year, reflecting a year-on-year gain of about 3.0%. The Earnings Per Share (EPS) is noted at ₹1.24, consistent with the previous period. Factors driving profitability include improved operational efficiency and a favorable change in the cost structure despite rising staff expenses.

Total operational expenses amount to ₹8.49 crore, up from ₹6.50 crore, representing a 30.6% increase. The main issues contributing to this rise are higher employee benefit expenses and other operational costs linked to recent expansions. However, effective cost management initiatives seem to be mitigating disproportionate effects on net profitability.

The balance sheet indicates total assets of ₹38.88 crore, with cash and cash equivalents notably improving to ₹19.78 crore from ₹19.17 crore, lending strength to its liquidity position. The debt levels are manageable, evidenced by a minimal long-term borrowing component.

Strategically, the company is focusing on service expansion and improving operational efficiencies which bode well for future growth. Market sentiment appears positive given the company's foundational works post-IPO, establishing it firmly in the healthcare space.

Considering the current operational performance, upcoming expansions, and robust cash flow management, this company can be seen as a *buy* for investors looking for exposure in the healthcare sector with promising upside potential.